COVIFOR, Antiviral Drug For COVID-19 by Indian Pharma Company Hetero, Priced at Rs 5,400 Per 100 Mg Vial in India
Covifor, the generic version of Covid-19 drug Remdesivir, will be available in India for Rs 5,400 per 100 mg vial, Hyderabad-based Hetero Labs announced on Wednesday. Following the approval to Covifor by the Drug Controller General of India, Hetero Healthcare Ltd, a group company of Hetero, announced that it is set to deliver the first set of 20,000 vials.